artificial eye, bio implant, ioi
patients  |  doctors  |  ocularists  |  distributors
line.gif (858 bytes)

Bio-eye Presentation Slide Set

Page 11 of 11

(Click image to enlarge)
101. Exposure of hydroxyapatite prior to vascularization. The Bio-eye orbital implant must be treated as any other implant until it has vascularized. Only then can it deliver its most desirable characteristics: low-levels of migration, exposure, extrusion, and excellent motility via the motility/support peg.

(Click image to enlarge)
102. Patient showing spontaneous healing over an exposed area. Most small exposures heal over spontaneously. Large (5-6 mm) or growing exposures must be covered with some graft material (e.g., dermis, sclera, fascia), which should then be covered with a conjunctival flap for blood supply.

103. Factors that may influence vascularization

  • Wrapping implant
  • Vascularity of orbit
  • Drilling holes to center of implant
  • Medical status of patient

One of the few inhibitors of good vascularization is an orbit with compromised vascularity due to radiation treatment.

104. Summary

  • Results have validated concepts
  • Well-vascularized implant should last a lifetime and give best motility
  • No extrusion or migration
  • Support artificial eye

The original hopes for this unique implant have all been validated by experience.

This is page 11 of 11

To go to the previous slide page